Outcomes of Late-Onset Bleb-Related Endophthalmitis Treated with Pars Plana Vitrectomy

Table 1

Characteristics of cases.

(a)

Case	Gender	Age; (years)	Type of glaucoma	PSITE; (days)	HPB; (+/−)	Bacteria/location	BCVA before infection; ( value)	BCVA after surgery; ( value)	IOP before BRE; (mmHg)	IOP after surgery; (mmHg)
1	Male	62	SOAG (Uveitis)	0	+	Enterococcus faecalis/V	0.10	3	8	12
2	Female	56	SOAG	2	+	S. pneumoniae/C	0.70	5	5	0
3	Male	73	POAG	2	+	S. pneumoniae/V	0.52	5	6	7
4	Male	53	SOAG (Uveitis)	2	+	Group A Str/C, A	−0.08	1.70	6	18
5	Female	68	SOAG (steroid)	3	+	Unidentifiable Str/I; GPR/C, V	0.40	0.40	14	16
6	Female	81	Congenital	7	+	S. mitis/A	1.52	5	7	2
7	Female	40	Congenital	0		No growth	0.22	0.70	15	30
8	Male	41	POAG	0		S. epidermidis/A	0	0	10	11
9	Female	62	SOAG	1		No growth	0.52	0.70	9	11
10	Female	30	Congenital	3		No growth	0.15	0.82	11	22
11	Male	53	POAG	4		GPR/C	−0.08	0.30	10	10

(b)

Case	Follow-up periods (years)	Period from LET to BRE (years)	General complications	Bleb leakage	Intraoperative laser treatment	Intravitreously administrated antibiotics during surgery	Antibiotic eye drops after surgery	Systemic antibiotics after PPV	Phakia, IOL, and aphakia
1	4.9	11	—		+	Vancomycin/ceftazidime	Levofloxacin/cefmenoxime	—	Phakia
2	5.0	2	Sjögren’s syndrome	+	+	Vancomycin/ceftazidime	Levofloxacin/cefmenoxime	—	Phakia
3	5.8	5	—		+	Vancomycin/ceftazidime	Levofloxacin/cefmenoxime	—	IOL
4	8.6	3	—	+	+	Imipenem	Sulpelin/erythromycin/; tobramycin	—	IOL
5	3.8	6	Dermatomyositis		+	Vancomycin/ceftazidime	Levofloxacin	Imipenem	IOL
6	0.2	16	Axenfeld-Rieger syndrome	+		Ceftazidime	Levofloxacin/cefmenoxime/; tobramycin/vancomycin	Imipenem/; ceftazidime	Phakia
7	0.7	7	—			Vancomycin/ceftazidime	Levofloxacin/cefmenoxime	Imipenem	Phakia
8	1.3	6	—	+		Vancomycin/ceftazidime	Gatifloxacin/cefmenoxime	—	IOL
9	3.0	1	Diabetic mellitus	+		Vancomycin/ceftazidime	Gatifloxacin/cefmenoxime/; vancomycin	Imipenem	IOL
10	2.6	17	—	+		Vancomycin/ceftazidime	Gatifloxacin/cefmenoxime	Flomoxef	Aphakia
11	0.8	9	—	+	+	Vancomycin/ceftazidime	Levofloxacin/cefmenoxime	—	Phakia

SOAG = secondary open angle glaucoma, POAG = primary open angle glaucoma, PSITE = the periods from starting symptom to initiation of treatment for endophthalmitis, HPB = highly pathogenic bacteria, V = vitreous specimen, C = conjunctival specimen, A = anterior chamber’s specimen, I = specimen of removed intraocular lens, BCVA = best corrected visual acuity, IOP = intraocular pressure, BRE = bleb-related endophthalmitis, S. pneumoniae = Streptococcus pneumoniae, group A Str = group A Streptococcus, S. mitis = Streptococcus mitis, unidentifiable Str = unidentifiable Streptococcus, group G Str = group G Streptococcus, S. epidermidis = Staphylococcus epidermidis, LET = trabeculectomy, PPV = pars plana vitrectomy, and IOL = intraocular lens.